Olema Pharmaceuticals Financial Overview
Olema Pharmaceuticals's market cap is currently $2.20B. The company's EPS TTM is $-0.49; its P/E ratio is -15.41; Olema Pharmaceuticals is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
